Get the Stockscreener App
0.6153
2.57%
0.0154
Elutia Inc stock is traded at $0.6153, with a volume of 345.00K.
It is up +2.57% in the last 24 hours and down -31.63% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$0.5999
Open:
$0.5863
24h Volume:
345.00K
Relative Volume:
1.31
Market Cap:
$25.02M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.2491
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
-11.63%
1M Performance:
-31.63%
6M Performance:
-64.23%
1Y Performance:
-85.21%
1-Day Range:
$0.58
$0.6303
1-Week Range:
$0.58
$0.7275
52-Week Range:
$0.58
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.62 | 25.62M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
128.26 | 221.17B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.36 | 145.34B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
375.81 | 141.58B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.43 | 132.37B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.75 | 49.16B | 5.88B | 1.34B | 799.60M | 2.3489 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Will Elutia Inc. stock recover faster than marketRate Hike & Safe Capital Growth Trade Ideas - newser.com
Director Makes Strategic Move with Significant Elutia Stock Purchase - TipRanks
Why Elutia Inc. stock appeals to analystsEntry Point & Short-Term Trading Opportunity Alerts - newser.com
Is Elutia Inc. building a consolidation baseWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - newser.com
What valuation multiples suggest for Elutia Inc. stockMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Visual trend scoring systems applied to Elutia Inc.Quarterly Trade Report & Safe Entry Momentum Tips - newser.com
Chart overlay techniques for tracking Elutia Inc.July 2025 Highlights & Verified Entry Point Signals - newser.com
Forecasting Elutia Inc. price range with options dataJuly 2025 Update & High Accuracy Swing Entry Alerts - newser.com
Why Analysts See a Shifting Story for Elutia After the BioEnvelope Sale - Yahoo Finance
Is Elutia Inc. showing signs of accumulation2025 Key Highlights & Safe Entry Zone Tips - newser.com
Is Elutia Inc a good long term investmentHigh Yield Income Stocks & Today’s Picks, Tomorrow’s Winners - earlytimes.in
How Elutia Inc. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
Trend analysis for Elutia Inc. this weekWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com
Elutia Completes Sale of BioEnvelope to Boston Scientific - MSN
Is Elutia Inc. stock positioned for digital transformationJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Analyzing recovery setups for Elutia Inc. investors2025 Short Interest & Reliable Price Action Trade Plans - newser.com
What sentiment indicators say about Elutia Inc. stockJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
What candlestick patterns are forming on Elutia Inc.Portfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
How to use a screener to detect Elutia Inc. breakoutsTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Real time breakdown of Elutia Inc. stock performanceJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Is Elutia Inc. reversing from oversold territoryEarnings Summary Report & Community Supported Trade Ideas - newser.com
Live market analysis of Elutia Inc.Market Trend Report & Safe Capital Growth Tips - newser.com
Aziyo Biologics Faces Nasdaq Delisting Risk Notice - TipRanks
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elutia Inc Stock (ELUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mills C Randal | PRESIDENT AND CEO |
Nov 13 '25 |
Buy |
0.75 |
13,500 |
10,110 |
353,785 |
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
1.11%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):